Freddie Mac
Federal Home Loan Mortgage Corporation operates in the secondary mortgage market in the United States. The company operates through two segments: Single-Family and Multifamily. The Single-Family segment purchases, securitizes, and guarantees single-family loans; and manages single-family mortgage credit and market risk, as well as manages mortgage-related investments portfolio, single-family secu… Read more
Freddie Mac (0IKZ) - Net Assets
Latest net assets as of September 2021: $25.31 Billion USD
Based on the latest financial reports, Freddie Mac (0IKZ) has net assets worth $25.31 Billion USD as of September 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.94 Trillion) and total liabilities ($2.91 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $25.31 Billion |
| % of Total Assets | 0.86% |
| Annual Growth Rate | 34.1% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 93.84 |
Freddie Mac - Net Assets Trend (2016–2020)
This chart illustrates how Freddie Mac's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Freddie Mac (2016–2020)
The table below shows the annual net assets of Freddie Mac from 2016 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | $16.41 Billion | +79.93% |
| 2019-12-31 | $9.12 Billion | +103.75% |
| 2018-12-31 | $4.48 Billion | +1534.94% |
| 2017-12-31 | $-312.00 Million | -106.15% |
| 2016-12-31 | $5.08 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Freddie Mac's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1083900000000.0% over the analyzed period, indicating profitable operations and earnings retention.
- The company has 23.7% of equity in treasury stock, representing shares repurchased from the open market.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Treasury Stock | $3.88 Billion | 23.67% |
| Other Components | $87.40 Billion | 532.50% |
| Total Equity | $16.41 Billion | 100.00% |
Freddie Mac Competitors by Market Cap
The table below lists competitors of Freddie Mac ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
WSFS Financial Corporation
NASDAQ:WSFS
|
$3.32 Billion |
|
JSC National Atomic Company Kazatomprom
PINK:NATKY
|
$3.32 Billion |
|
Adtalem Global Education Inc
NYSE:ATGE
|
$3.32 Billion |
|
Exponent Inc
NASDAQ:EXPO
|
$3.32 Billion |
|
EDENRED UNSP.ARD 1/2 EO 2
F:QSV0
|
$3.32 Billion |
|
Oscar Health Inc
NYSE:OSCR
|
$3.31 Billion |
|
Hitachi Construction Machinery Co. Ltd
F:HCM
|
$3.31 Billion |
|
Hainan HNA Infrastructure Investment Group Co Ltd
SHG:600515
|
$3.31 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Freddie Mac's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 9,122,000,000 to 16,413,000,000, a change of 7,291,000,000 (79.9%).
- Net income of 7,326,000,000 contributed positively to equity growth.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $7.33 Billion | +44.64% |
| Other Changes | $-35.00 Million | -0.21% |
| Total Change | $- | 79.93% |
Book Value vs Market Value Analysis
This analysis compares Freddie Mac's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Freddie Mac utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 44.64%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.13%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 160.08x
- Recent ROE (44.64%) is below the historical average (96.80%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 153.99% | 13.19% | 0.03x | 398.69x | $7.31 Billion |
| 2017 | 0.00% | 8.86% | 0.03x | 0.00x | $5.66 Billion |
| 2018 | 206.28% | 14.26% | 0.03x | 460.81x | $8.79 Billion |
| 2019 | 79.08% | 9.90% | 0.03x | 240.49x | $6.30 Billion |
| 2020 | 44.64% | 11.13% | 0.03x | 160.08x | $5.68 Billion |
Industry Comparison
This section compares Freddie Mac's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Freddie Mac (0IKZ) | $25.31 Billion | 153.99% | 115.08x | $3.32 Billion |
| Nyfosa AB (0A0K) | $3.48 Billion | 34.90% | 2.92x | $966.63 Million |
| Tethys Oil AB (0A1V) | $56.23 Million | 21.07% | 0.01x | $122.95 Million |
| High Templar Tech Limited (0A2T) | $11.29 Billion | 0.81% | 0.10x | $258.25 Million |
| Strategy Inc (0A7O) | $361.50 Million | 1.39% | 0.55x | $38.08 Billion |
| NACON SASU (0A9N) | $210.72 Million | 8.63% | 0.51x | $7.82 Million |
| Antin Infrastructure Partners (0AA5) | $32.26 Million | 152.50% | 1.23x | $545.92 Million |
| Truecaller AB Series B (0AA7) | $1.51 Billion | 34.81% | 0.30x | $277.14 Million |
| Brockhaus Technologies AG (0AAW) | $315.34 Million | 15.55% | 1.46x | $74.17 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $-10.19 Million | 0.00% | 0.00x | $71.96 Million |
| Kalray S.A. (0ABT) | $39.07 Million | -59.55% | 1.26x | $33.84 Million |